Magnetic Resonance Imaging as a Prognostic Disability Marker in Clinically Isolated Syndrome and Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Amjad I AltokhisAbrar AlAmraniAbdulmajeed AlotaibiAnna PodlasekCris S ConstantinescuPublished in: Diagnostics (Basel, Switzerland) (2022)
To date, there are no definite imaging predictors for long-term disability in multiple sclerosis (MS). Magnetic resonance imaging (MRI) is the key prognostic tool for MS, primarily at the early stage of the disease. Recent findings showed that white matter lesion (WML) counts and volumes could predict long-term disability for MS. However, the prognostic value of MRI in the early stage of the disease and its link to long-term physical disability have not been assessed systematically and quantitatively. A meta-analysis was conducted using studies from four databases to assess whether MS lesion counts and volumes at baseline MRI scans could predict long-term disability, assessed by the expanded disability status scale (EDSS). Fifteen studies were eligible for the qualitative analysis and three studies for meta-analysis. T2 brain lesion counts and volumes after the disease onset were associated with disability progression after 10 years. Four or more lesions at baseline showed a highly significant association with EDSS 3 and EDSS 6, with a pooled OR of 4.10 and 4.3, respectively. The risk increased when more than 10 lesions were present. This review and meta-analysis confirmed that lesion counts and volumes could be associated with disability and might offer additional valid guidance in treatment decision making. Future work is essential to determine whether these prognostic markers have high predictive potential.
Keyphrases
- multiple sclerosis
- white matter
- magnetic resonance imaging
- early stage
- contrast enhanced
- systematic review
- computed tomography
- case control
- squamous cell carcinoma
- decision making
- diffusion weighted imaging
- high resolution
- magnetic resonance
- radiation therapy
- ms ms
- randomized controlled trial
- physical activity
- mental health
- risk assessment
- functional connectivity
- brain injury
- photodynamic therapy
- lymph node
- climate change
- neoadjuvant chemotherapy
- study protocol
- sentinel lymph node
- current status
- resting state
- combination therapy
- cerebral ischemia
- case report
- deep learning
- placebo controlled
- double blind